Therefore, the miR-1307-5p/TRAF3/NF-κB/MAPK axis may be a new target for the treatment of human lung adenocarcinoma and may be further identified as a potential prognostic factor in the future. The gene discussed is TRAF3; the disease is lung adenocarcinoma.